Search

everythinglearnresearchcommunity

for

Search:↓

Metformin for PCOS can rarely cause side effects like joint pain and behavior changes.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

People with metabolic syndrome get gray hair earlier.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Men with severe hair loss are more likely to have metabolic syndrome, a condition linked to heart disease.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Even a small melanoma can be deadly if not removed, regardless of the patient's age.

Methyl prednisolone helps most patients with alopecia universalis regrow hair.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Early-onset male baldness may increase the risk of metabolic syndrome.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Metabolites and diet affect hair growth cycles in cashmere goats.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

STK11 gene polymorphism does not predict metformin response in PCOS.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

PlacMA hydrogels from human placenta are versatile and useful for cell culture and tissue engineering.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Low dose methotrexate does not increase hair fall and may reduce it.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.